The overall mission of the Oncology Department is to improve cure rates for children with cancer while reducing the side effects of therapy through a coordinated program of clinical and laboratory-based research, patient care and education. Recent gains have been seen in the treatment outcome for two of the most frequent forms of childhood cancer (a 94 percent survival rate for acute lymphoblastic leukemia and 71 percent for acute myeloid leukemia).
Oncology faculty share their unique clinical expertise with colleagues worldwide through St. Jude Global. They are also involved in all programs of the Cancer Center through research aiming at identifying novel drugs and treatment modalities, defining the clinical significance of recently discovered genetic abnormalities of cancer cells, and understanding mechanisms of cancer development and drug resistance. The ultimate goals of this research are to provide curative therapy to every child with cancer and help develop preventive measures.
From the Pediatric Cancer Genome Project and beyond, @stjuderesearch has a long history of genetic discovery. Read about the work of our scientists on the genetics of vulnerabilities, predisposition, molecular groups and data analysis. #StJudeOn
Stay up-to-date on St. Jude's ongoing effort to end childhood cancer and other catastrophic diseases: @StJudeResearch on Twitter
DNA isn't destiny, but genetic predispositions do underlie many cancers. St. Jude scientists have gained a nuanced understanding of cancer predisposition and are learning more to help personalize patient therapies. Learn more. #StJudeOn
Cancer is not a monolith but a landscape of diseases with different drivers. Scientists at St. Jude are leading studies on how understanding molecular groups can advance cancer care. Read about it. #StJudeOn
Studying genomics means creating big data. Scientists at St. Jude have developed numerous tools and techniques for tackling data with cutting-edge visualizations and analysis. Learn more. #StJudeOn
The Division of Cancer Predisposition promotes cutting-edge clinical, translational and basic research related to genetic predisposition to childhood cancer.
The mission of the Division of Cancer Survivorship at St. Jude Children's Research Hospital is simple: We aim to improve quality of life among adults who survived all types of pediatric cancer.
The Leukemia/Lymphoma division aims to advance cure rates for children with leukemia and lymphoma, while minimizing acute and late sequelae of therapy
The Division of Molecular Oncology investigates the molecular and cellular determinants that lead to tumor formation and that dictate cellular responses to cytotoxic stresses.
The Neuro-Oncology division at St. Jude works advances knowledge related to the etiology, biology, treatment, and eventually cures of brain tumors in children
The Division of Quality of Life and Palliative Care provides patient and family-centered physical, emotional and spiritual care
The Solid Tumor division develops and tests novel therapeutics for the treatment of pediatric solid tumors, particularly those at high risk of treatment failure
Department of Oncology
MS 260, Room C6056
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Telephone: (901) 595-4329
Fax: (901) 521-1751
Preferred contact method: email